BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 15657067)

  • 1. Phosphotyrosine signaling networks in epidermal growth factor receptor overexpressing squamous carcinoma cells.
    Thelemann A; Petti F; Griffin G; Iwata K; Hunt T; Settinari T; Fenyo D; Gibson N; Haley JD
    Mol Cell Proteomics; 2005 Apr; 4(4):356-76. PubMed ID: 15657067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Related adhesion focal tyrosine kinase and the epidermal growth factor receptor mediate the stimulation of mitogen-activated protein kinase by the G-protein-coupled P2Y2 receptor. Phorbol ester or [Ca2+]i elevation can substitute for receptor activation.
    Soltoff SP
    J Biol Chem; 1998 Sep; 273(36):23110-7. PubMed ID: 9722539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells. Modulation of EGF-induced trafficking and signaling.
    Huang Y; Kim SO; Jiang J; Frank SJ
    J Biol Chem; 2003 May; 278(21):18902-13. PubMed ID: 12642595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of GRB2-associated binder 1 in epidermal growth factor receptor-induced signaling in head and neck squamous cell carcinoma.
    Hoeben A; Martin D; Clement PM; Cools J; Gutkind JS
    Int J Cancer; 2013 Mar; 132(5):1042-50. PubMed ID: 22865653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gbetagamma subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activation.
    Luttrell LM; Della Rocca GJ; van Biesen T; Luttrell DK; Lefkowitz RJ
    J Biol Chem; 1997 Feb; 272(7):4637-44. PubMed ID: 9020193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFR blockade by tyrosine kinase inhibitor or monoclonal antibody inhibits growth, directs terminal differentiation and induces apoptosis in the human squamous cell carcinoma HN5.
    Modjtahedi H; Affleck K; Stubberfield C; Dean C
    Int J Oncol; 1998 Aug; 13(2):335-42. PubMed ID: 9664130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 (Iressa) suppresses c-Src and Pak1 pathways and invasiveness of human cancer cells.
    Yang Z; Bagheri-Yarmand R; Wang RA; Adam L; Papadimitrakopoulou VV; Clayman GL; El-Naggar A; Lotan R; Barnes CJ; Hong WK; Kumar R
    Clin Cancer Res; 2004 Jan; 10(2):658-67. PubMed ID: 14760089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosine phosphorylation of Cbl upon epidermal growth factor (EGF) stimulation and its association with EGF receptor and downstream signaling proteins.
    Fukazawa T; Miyake S; Band V; Band H
    J Biol Chem; 1996 Jun; 271(24):14554-9. PubMed ID: 8662998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transactivated epidermal growth factor receptor recruits Pyk2 to regulate Src kinase activity.
    Schauwienold D; Sastre AP; Genzel N; Schaefer M; Reusch HP
    J Biol Chem; 2008 Oct; 283(41):27748-27756. PubMed ID: 18667434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying novel targets of oncogenic EGF receptor signaling in lung cancer through global phosphoproteomics.
    Zhang X; Belkina N; Jacob HK; Maity T; Biswas R; Venugopalan A; Shaw PG; Kim MS; Chaerkady R; Pandey A; Guha U
    Proteomics; 2015 Jan; 15(2-3):340-55. PubMed ID: 25404012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecystokinin stimulates extracellular signal-regulated kinase through activation of the epidermal growth factor receptor, Yes, and protein kinase C. Signal amplification at the level of Raf by activation of protein kinase Cepsilon.
    Piiper A; Elez R; You SJ; Kronenberger B; Loitsch S; Roche S; Zeuzem S
    J Biol Chem; 2003 Feb; 278(9):7065-72. PubMed ID: 12496267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic analysis of the epidermal growth factor receptor by mass spectrometry reveals stimulation-dependent multisite phosphorylation.
    Boeri Erba E; Bergatto E; Cabodi S; Silengo L; Tarone G; Defilippi P; Jensen ON
    Mol Cell Proteomics; 2005 Aug; 4(8):1107-21. PubMed ID: 15901825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein-tyrosine-phosphatase-mediated epidermal growth factor (EGF) receptor transinactivation and EGF receptor-independent stimulation of mitogen-activated protein kinase by bradykinin in A431 cells.
    Graness A; Hanke S; Boehmer FD; Presek P; Liebmann C
    Biochem J; 2000 Apr; 347(Pt 2):441-7. PubMed ID: 10749673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The protein kinase C inhibitor Go6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] potentiates agonist-induced mitogen-activated protein kinase activation through tyrosine phosphorylation of the epidermal growth factor receptor.
    Shah BH; Olivares-Reyes JA; Catt KJ
    Mol Pharmacol; 2005 Jan; 67(1):184-94. PubMed ID: 15465928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caveolin-1 phosphorylation in human squamous and epidermoid carcinoma cells: dependence on ErbB1 expression and Src activation.
    Kim YN; Dam P; Bertics PJ
    Exp Cell Res; 2002 Oct; 280(1):134-47. PubMed ID: 12372346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of erlotinib on epidermal growth factor receptor and downstream signaling in oral cavity squamous cell carcinoma.
    Tsien CI; Nyati MK; Ahsan A; Ramanand SG; Chepeha DB; Worden FP; Helman JI; D'Silva N; Bradford CR; Wolf GT; Lawrence TS; Eisbruch A
    Head Neck; 2013 Sep; 35(9):1323-30. PubMed ID: 22907806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of proline-rich tyrosine kinase 2 in platelet activation: tyrosine phosphorylation mostly dependent on alphaIIbbeta3 integrin and protein kinase C, translocation to the cytoskeleton and association with Shc through Grb2.
    Ohmori T; Yatomi Y; Asazuma N; Satoh K; Ozaki Y
    Biochem J; 2000 Apr; 347(Pt 2):561-9. PubMed ID: 10749687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of extracellular signal-regulated kinase 1 and 2, protein kinase B, and signal transducer and activator of transcription 3 are differently inhibited by an epidermal growth factor receptor inhibitor, EKB-569, in tumor cells and normal human keratinocytes.
    Nunes M; Shi C; Greenberger LM
    Mol Cancer Ther; 2004 Jan; 3(1):21-7. PubMed ID: 14749472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GIT1 mediates Src-dependent activation of phospholipase Cgamma by angiotensin II and epidermal growth factor.
    Haendeler J; Yin G; Hojo Y; Saito Y; Melaragno M; Yan C; Sharma VK; Heller M; Aebersold R; Berk BC
    J Biol Chem; 2003 Dec; 278(50):49936-44. PubMed ID: 14523024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysophosphatidic acid inhibits Ca2+ signaling in response to epidermal growth factor receptor stimulation in human astrocytoma cells by a mechanism involving phospholipase C(gamma) and a G(alphai) protein.
    Hernández M; Barrero MJ; Crespo MS; Nieto ML
    J Neurochem; 2000 Oct; 75(4):1575-82. PubMed ID: 10987838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.